uniQure Ownership | Who Owns uniQure?

Overview Forecast RevenueFinancials Chart Transcripts

uniQure Ownership Summary

uniQure is owned by 104.79% institutional investors, 1.26% insiders. Avoro capital advisors is the largest institutional shareholder, holding 10.72% of QURE shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.39% of its assets in uniQure shares.

QURE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	uniQure	104.79%	1.26%	-6.05%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Biotech Stocks	379.61%	11.70%	-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Avoro capital advisors	6.73M	10.72%	$309.88M
Jpmorgan chase	4.87M	7.76%	$230.81M
Ecor1 capital	3.99M	7.28%	$232.84M
Rtw investments, lp	3.94M	6.28%	$181.55M
State street	2.90M	4.63%	$133.75M
Abrdn	2.85M	4.54%	$131.18M
Blackrock	1.93M	3.98%	$8.63M
Blackrock funding, inc. /de	1.88M	2.99%	$86.48M
Orbimed advisors	1.81M	2.88%	$83.25M
Jane street group	1.61M	2.57%	$74.18M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ecor1 capital	3.99M	11.17%	$232.84M
Mak capital one	1.23M	7.95%	$56.75M
Boxer capital management	1.50M	5.21%	$69.24M
Fourworld capital management	87.00K	3.65%	$4.01M
Monashee investment management	45.00K	3.48%	$2.07M
Bioimpact capital	1.23M	3.44%	$56.46M
Lion point capital, lp	14.70K	3.24%	$677.08K
First turn management	608.92K	3.00%	$28.05M
Boone capital management	147.32K	2.82%	$8.60M
Avoro capital advisors	6.73M	2.78%	$309.88M

Top Buyers

Holder	Shares	% Assets	Change
Jpmorgan chase	4.87M	0.01%	2.03M
Rtw investments, lp	3.94M	1.55%	1.36M
Jane street group	1.61M	0.01%	974.49K
Boxer capital management	1.50M	5.21%	841.30K
Longaeva partners	804.59K	0.81%	804.59K

Top Sellers

Holder	Shares	% Assets	Change
Abrdn	2.85M	0.18%	-2.46M
Suvretta capital management	-	-	-1.22M
Two sigma investments, lp	1.46M	0.05%	-1.21M
Artia global partners lp	-	-	-1.02M
Siren	-	-	-1.00M

New Positions

Holder	Shares	% Assets	Change	Value
Longaeva partners	804.59K	0.81%	804.59K	$37.06M
Invesco	627.82K	0.00%	627.82K	$28.92M
Kinetic partners management, lp	581.00K	0.64%	581.00K	$26.76M
Gilder gagnon howe	530.98K	0.25%	530.98K	$24.46M
Rubric capital management lp	408.58K	0.17%	408.58K	$18.82M

Sold Out

Holder	Change
Whipplewood advisors	-1.00
Nbc securities	-2.00
Northwestern mutual wealth management	-3.00
Root financial partners	-14.00
Principal securities	-19.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	300	15.83%	65,748,638	10.17%	104	0.97%	179	46.72%	62	-7.46%
Mar 31, 2026	140	-46.36%	21,874,516	-64.64%	38	0.34%	66	-54.48%	39	-40.91%
Dec 31, 2025	175	-32.17%	37,757,618	-31.79%	64	0.72%	97	-36.60%	43	-31.75%
Sep 30, 2025	253	45.40%	55,350,112	4.51%	100	1.08%	150	105.48%	61	7.02%
Jun 30, 2025	170	3.66%	52,946,969	5.89%	96	1.09%	75	2.74%	54	31.71%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
State Street® SPDR® S&P® Biotech ETF	2.35M	3.39%	5.41K
RTW Biotech Opportunities Ord	1.39M	2.57%	1.39M
JPMorgan Growth Advantage A	1.24M	1.78%	695.09K
SPDR® S&P Biotech ETF	838.29K	1.53%	1.87K
Delaware Healthcare I	706.17K	1.45%	-
JPM US Mid Cap Growth-Composite	959.05K	1.39%	395.40K
JPMorgan Mid Cap Growth I	959.05K	1.38%	405.18K
Macquarie Healthcare I	706.17K	1.29%	-
JPM US Growth Advantage-MA	860.82K	1.25%	387.47K
abrdn Healthcare Investors	785.12K	1.13%	-364.77K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 02, 2026	Kapusta Matthew C	CEO, Managing Director	Sell	$348.76K
Jul 02, 2026	Kapusta Matthew C	CEO, Managing Director	Sell	$194.53K
Jul 02, 2026	Kapusta Matthew C	CEO, Managing Director	Sell	$408.76K
Jun 30, 2026	Abi-Saab Walid	Chief Medical Officer	Sell	$464.60K
Jun 30, 2026	Abi-Saab Walid	Chief Medical Officer	Sell	$928.00K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	35
2026 Q1	-	14
2025 Q4	-	5
2025 Q3	-	7
2025 Q2	-	9

QURE Ownership FAQ

Who Owns uniQure?

uniQure shareholders are primarily institutional investors at 104.79%, followed by 1.26% insiders and -6.05% retail investors. The average institutional ownership in uniQure's industry, Biotech Stocks , is 379.61%, which uniQure falls below.

Who owns the most shares of uniQure?

uniQure’s largest shareholders are Avoro capital advisors (6.73M shares, 10.72%), Jpmorgan chase (4.87M shares, 7.76%), and Ecor1 capital (3.99M shares, 7.28%). Together, they hold 25.76% of uniQure’s total shares outstanding.

Does Blackrock own uniQure?

Yes, BlackRock owns 3.98% of uniQure, totaling 1.93M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.63M$. In the last quarter, BlackRock increased its holdings by 65.08K shares, a 3.50% change.

Who is uniQure’s biggest shareholder by percentage of total assets invested?

Ecor1 capital is uniQure’s biggest shareholder by percentage of total assets invested, with 11.17% of its assets in 3.99M uniQure shares, valued at 232.84M$.

Who is the top mutual fund holder of uniQure shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of uniQure shares, with 3.39% of its total shares outstanding invested in 2.35M uniQure shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools